Equity Capital Markets

Company · CIK 1869105

BridgeBio Oncology Therapeutics, Inc.

CIK1869105 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedBBOT (Nasdaq)
First annual or quarterly report2024-05-15

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-298697
ShelfEffective
 2026-09-012026-09-102
333-289940
Registered companyEffective
 2025-08-292026-09-084
333-276591
IPOFinal prospectus
 2024-01-182024-02-135

Filings

16
FiledFilingRegistrationAccession
2026-09-10EFFECTDeclared effective 333-2986979999999995-26-002939
2026-09-08EFFECTDeclared effective 333-2899409999999995-26-002909
2026-09-01S-3Shelf registered 333-2986970001193125-26-378637
2026-05-04EFFECTDeclared effective 333-2899409999999995-26-001459
2025-09-10EFFECTDeclared effective 333-2899409999999995-25-002915
2025-08-29S-1Registration filed 333-2899400001193125-25-192760
2025-08-19EFFECTDeclared effective 333-2882229999999995-25-002673
2025-07-10EFFECTDeclared effective 333-2882229999999995-25-002217
2025-07-10424B4Final prospectus 333-2882220001213900-25-062864
2025-04-15DRSDraft made public 377-078950001213900-25-031720
2024-02-13424B4Final prospectus 333-2765910001213900-24-012731
2024-02-08EFFECTDeclared effective 333-2765919999999995-24-000357
2024-02-07S-1/AAmendment 333-2765910001213900-24-010676
2024-02-02S-1/AAmendment 333-2765910001213900-24-009481
2024-01-18S-1Registration filed 333-2765910001213900-24-004590
2023-12-20DRSDraft made public 377-070100001213900-23-097208

All filings of this company · CSV